All the news Showing 10 of 129 articles from: Health services, policy and advocacyGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources London sets out route map for hepatitis C elimination Keith Alcorn / 13 March 2020 Healthcare professionals, local government and community organisations have launched a London route map for hepatitis C elimination, setting out five 'opportunity' areas for an intensified focus on reaching undiagnosed people and vulnerable populations ... Increase in clean needle and syringe provision essential for hepatitis C elimination Keith Alcorn / 12 February 2020 Elimination of hepatitis C will not be achievable without substantial improvements in provision of sterile injecting equipment, Dr Magdalena Harris of London School of Hygiene and Tropical Medicine told a conference on hepatitis ... London: hepatitis C elimination depends on testing scale-up Keith Alcorn / 28 January 2020 London needs to step up the rate of testing for hepatitis C if it is to achieve elimination of hepatitis C, Professor Graham Foster of Queen Mary University London told the London ... Peer-led outreach improves uptake of hepatitis C care among homeless and people who use drugs Keith Alcorn / 24 January 2020 Intensive peer support during engagement with hepatitis C care was associated with a high level of engagement in care among vulnerable people including recently homeless people and people who inject drugs in London, ... HepCheck screening programme links 80% to hepatitis C care in 4 European countries Keith Alcorn / 21 January 2020 Hepatitis C screening programmes targeting the homeless, people who inject drugs and prisoners achieved linkage to specialist care in over 80% of people diagnosed with hepatitis C, a four-country European study found. The study ... Coalition of liver associations calls for simplifying hepatitis C care Liz Highleyman / 13 November 2019 Leaders of liver disease associations from Europe, the United States, Latin America and Asia issued a global call to action at the AASLD Liver Meeting this week in Boston, aiming to advance ... Voluntary licensing of hepatitis C drugs has led to more people on treatment Keith Alcorn / 28 August 2019 Voluntary licensing of hepatitis C treatments to generic drug manufacturers for sale in lower- and middle-income countries has increased the number of people treated by approximately 70 per thousand people diagnosed with hepatitis ... How much can 'Netflix'-style pricing for hepatitis C drugs save? Keith Alcorn / 03 June 2019 A 'Netflix'-style pricing agreement that allows the Australian government to treat an unlimited number of people with hepatitis C for AU$1 billion may result in savings close to US$5 billion, according to ... World Health Organization calls for greater focus on people who inject drugs in HCV treatment scale-up plans Keith Alcorn / 30 April 2019 The World Health Organization (WHO) has called for greater commitments to scale up hepatitis C virus (HCV) testing and treatment services to people who inject drugs and people in prisons. In an analysis ... Hepatitis elimination by 2030 in doubt as countries fail to scale up diagnosis and treatment Keith Alcorn / 24 April 2019 Most countries will struggle to eliminate hepatitis C by 2030 due to lack of investment and political will, missing an internationally agreed target set by the World Health Organization, The International Liver Congress ... ← Prev1...23456...13Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Access to medicines & diagnostics Hepatitis C elimination Models of care Finance, funding & health economics National policy European policy International policy Activism and civil society Pharmaceutical industry Social issues Conference news Email bulletin archive